FDA updates Tecfidera label with info on patient's death from PML

Biogen Idec ($BIIB) reported last month that a patient taking its hot multiple sclerosis pill Tecfidera had developed a rare brain infection and died. Now, the FDA has decided the death was important enough to mention on Tecfidera labels. The patient wasn't taking any other drugs associated with progressive multifocal leukoencephalopathy (PML) or any other meds that affect the immune system, the agency said. Report

Suggested Articles

A self-proclaimed former employee at Novartis’ Beijing office accused the Swiss drugmaker of expensing fake academic events to offer kickbacks to doctors.

Novo Nordisk just won an FDA approval that could help it stand out in the crowded—and competitive—basal insulin category.

Pfizer is training pharmacists in the U.K. to handle over-the-counter Viagra.